Jos Lamers
Pharmaceutical Sciences
Unilabs
Switzerland
Biography
He joined Unilabs in October 2013 as Chief Executive Officer. Prior to joining Unilabs, Mr. Lamers was CEO of Nucletron, a radiotherapy company and global leader in brachytherapy that was acquired by Elekta in 2011. He led the turn-around of Nucletron and subsequently oversaw its successful sale from private equity ownership to Elekta in 2011. Before that, Mr. Lamers was a Regional President and member of the Executive Management Board at Eurofins. Eurofins Scientific is the world leader in food and bio/ pharma products testing, as well as being one of the global market leaders in central laboratory services.
Research Interest
Pharmaceutical Sciences
